Literature DB >> 8566883

Performance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curve.

R Guarnone1, E Centenara, G Barosi.   

Abstract

The Hemox-Analyzer (TCS, Medical Products Division, Southampton, PA) is an automatic system for determining the oxyhemoglobin dissociation curve (ODC) and P50 values. The ODC is recorded during deoxygenation with nitrogen gas and plotted on graph paper; the oxygen tension is detected by a Clark electrode, while the oxyhemoglobin fraction (%HbO2) is evaluated by a dual-wavelength spectrophotometer. Even though this instrument has been commercially available for more than 20 years, its performance characteristics have been assessed. We evaluated the performance characteristics of the Hemox-Analyzer. P50 was tested in 28 healthy volunteers, in 16 anemic and in 9 polycythemic patients. To test its precision we evaluated both inter- and intra-assay variability. The system shows good precision: standard deviation was 0.39 for assays in duplicate, CV = 1.9% for intra-assay and CV = 3.0% for inter-assay measurements. The mean P50 values were 25.2 +/- 1.5 mmHg in normal volunteers and 27.3 +/- 1.4 mmHg in anemic patients. The Hemox-Analyzer is a simple, quick and reliable instrument for recording the oxyhemoglobin dissociation curve. Both the P50 value and observation of the fine structure of the curve can furnish information about the delivery of oxygen to tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566883

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  16 in total

1.  Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.

Authors:  C A Head; C Brugnara; R Martinez-Ruiz; R M Kacmarek; K R Bridges; D Kuter; K D Bloch; W M Zapol
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Effect of cilostazol on the p50 of the oxygen-hemoglobin dissociation curve.

Authors:  Marshalyn McKoy; Kyomi Allen; Andrea Richards; Dagogo Pepple
Journal:  Int J Angiol       Date:  2015-03

3.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

4.  Hemoglobin conjugates with antioxidant enzymes (hemoglobin-superoxide dismutase-catalase) via poly(ethylene glycol) crosslinker for protection of pancreatic beta RINm5F cells in hypoxia.

Authors:  Venkatareddy Nadithe; You Han Bae
Journal:  Tissue Eng Part A       Date:  2011-07-11       Impact factor: 3.845

5.  Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity.

Authors:  M T Gladwin; A N Schechter; J H Shelhamer; L K Pannell; D A Conway; B W Hrinczenko; J S Nichols; M E Pease-Fye; C T Noguchi; G P Rodgers; F P Ognibene
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

6.  Hemoglobin-based O2 carrier O2 affinity and capillary inlet pO2 are important factors that influence O2 transport in a capillary.

Authors:  Michael L Dimino; Andre F Palmer
Journal:  Biotechnol Prog       Date:  2007-06-08

7.  Rat red blood cell storage lesions in various additive solutions.

Authors:  Vivek P Jani; Ozlem Yalcin; Alexander T Williams; Mark A Popovsky; Pedro Cabrales
Journal:  Clin Hemorheol Microcirc       Date:  2017       Impact factor: 2.375

Review 8.  Drug-loaded erythrocytes: on the road toward marketing approval.

Authors:  Vanessa Bourgeaux; José M Lanao; Bridget E Bax; Yann Godfrin
Journal:  Drug Des Devel Ther       Date:  2016-02-11       Impact factor: 4.162

9.  CD73 and AMPD3 deficiency enhance metabolic performance via erythrocyte ATP that decreases hemoglobin oxygen affinity.

Authors:  William G O'Brien; Vladimir Berka; Ah-Lim Tsai; Zhaoyang Zhao; Cheng Chi Lee
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

10.  Chemical Transport Knockout for Oxidized Vitamin C, Dehydroascorbic Acid, Reveals Its Functions in vivo.

Authors:  Hongbin Tu; Yu Wang; Hongyan Li; Lauren R Brinster; Mark Levine
Journal:  EBioMedicine       Date:  2017-08-22       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.